Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Clinics (Sao Paulo) ; 75: e1554, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32215455

RESUMO

Opioids are the main group of pharmacological agents used during the perioperative period and provide a sedative and analgesic component. The observations of opioid consumption in West Europe indicate that this group of drugs is widely used in chronic noncancer pain therapy. Nearly 20 years ago, the first publications indicating that opioids, as an element of perioperative pharmacotherapy in oncologic patients, increase the risk of tumor recurrence and affect further prognosis were presented. The actual publications suggest that there are multifactorial, complex mechanisms underlying the immunological impact and carcinogenesis promotion of opioids and that the intensity varies depending on the type of opioid. There are also questions about the immunosuppressive effects among patients receiving opioids in the treatment of chronic noncancer pain. The aim of the review article is to present information about the action of opioids on the immune system in carcinogenic settings and to define the clinical usefulness of this pharmacological phenomenon.


Assuntos
Analgésicos Opioides/efeitos adversos , Carcinogênese , Dor Crônica/tratamento farmacológico , Analgésicos Opioides/uso terapêutico , Tolerância a Medicamentos , Feminino , Humanos , Sistema Hipotálamo-Hipofisário/efeitos dos fármacos , Masculino , Transtornos Relacionados ao Uso de Opioides , Sistema Hipófise-Suprarrenal/efeitos dos fármacos , Estudos Retrospectivos
2.
Clinics ; Clinics;75: e1554, 2020.
Artigo em Inglês | LILACS | ID: biblio-1089608

RESUMO

Opioids are the main group of pharmacological agents used during the perioperative period and provide a sedative and analgesic component. The observations of opioid consumption in West Europe indicate that this group of drugs is widely used in chronic noncancer pain therapy. Nearly 20 years ago, the first publications indicating that opioids, as an element of perioperative pharmacotherapy in oncologic patients, increase the risk of tumor recurrence and affect further prognosis were presented. The actual publications suggest that there are multifactorial, complex mechanisms underlying the immunological impact and carcinogenesis promotion of opioids and that the intensity varies depending on the type of opioid. There are also questions about the immunosuppressive effects among patients receiving opioids in the treatment of chronic noncancer pain. The aim of the review article is to present information about the action of opioids on the immune system in carcinogenic settings and to define the clinical usefulness of this pharmacological phenomenon.


Assuntos
Humanos , Masculino , Feminino , Dor Crônica/tratamento farmacológico , Carcinogênese , Analgésicos Opioides/efeitos adversos , Sistema Hipófise-Suprarrenal/efeitos dos fármacos , Estudos Retrospectivos , Tolerância a Medicamentos , Analgésicos Opioides/uso terapêutico , Sistema Hipotálamo-Hipofisário/efeitos dos fármacos , Transtornos Relacionados ao Uso de Opioides
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA